-
Loading metrics
Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo
- Maria Beconi,
- Omar Aziz,
- Kim Matthews,
- Lara Moumné,
- Catherine O’Connell,
- Dawn Yates,
- Steven Clifton,
- Hannah Pett,
- Julie Vann,
- Lynsey Crowley
x
- Published: September 4, 2012
- https://doi.org/10.1371/journal.pone.0044498